Title:
PRMT5 INHIBITOR
Document Type and Number:
WIPO Patent Application WO/2023/001133
Kind Code:
A1
Abstract:
A PRMT5 kinase inhibitor, a pharmaceutical composition containing the compound, and a method for using the compound to treat a cell proliferative disease such as cancer.
Inventors:
FU JIASHENG (CN)
QIN HUA (CN)
ZHU WEIBO (CN)
SHI GUQIN (CN)
SUN DAQING (CN)
QIN HUA (CN)
ZHU WEIBO (CN)
SHI GUQIN (CN)
SUN DAQING (CN)
Application Number:
PCT/CN2022/106401
Publication Date:
January 26, 2023
Filing Date:
July 19, 2022
Export Citation:
Assignee:
SHANGHAI QILU PHARMACEUTICAL RES AND DEVELOPMENT CENTRE LTD (CN)
International Classes:
A61K31/519; C07D487/04; A61P35/00; A61P35/02
Domestic Patent References:
| WO2020198323A1 | 2020-10-01 | |||
| WO2020205867A1 | 2020-10-08 | |||
| WO2021079302A1 | 2021-04-29 | |||
| WO2021081211A1 | 2021-04-29 |
Foreign References:
| CN107922413A | 2018-04-17 | |||
| CN111527099A | 2020-08-11 | |||
| CN112805006A | 2021-05-14 |
Attorney, Agent or Firm:
PATENTSINO IP FIRM (CN)
Download PDF: